Glenmark's cholesterol-lowering agent ezetimibe gets US FDA tentative approval

Glenmark Generics Ltd's US subsidiary announced that the US FDA has granted tentative approval for the generic version of Schering Plough and MSP Singapore Company LLC's hypercholesterolemia treatment Zetia (ezetimibe).

The details can be read here.